Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Survival in multiple myeloma and SARS‐COV‐2 infection through the COVID‐19 pandemic: Results from the EPICOVIDEHA registry
Pellegrino Musto, Jon Salmanton‐García, Nicola Sgherza, et al.
Hematological Oncology (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 9

Showing 9 citing articles:

Follow-up of humoral and cellular immune responses after the third SARS-CoV-2 vaccine dose in multiple myeloma patients
Vincenzo Raimondi, Paola Storti, Rosanna Vescovini, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Endothelial injury and dysfunction with emerging immunotherapies in multiple myeloma, the impact of COVID-19, and endothelial protection with a focus on the evolving role of defibrotide
Clifton C. Mo, Edward Richardson, Eleonora Calabretta, et al.
Blood Reviews (2024) Vol. 66, pp. 101218-101218
Open Access | Times Cited: 1
Risk of SARS-CoV-2 infection and severe COVID-19 in hematological patients who received or not pre-exposure prophylaxis with tixagevimab/cilgavimab: a target trial emulation
Marco Falcone, Giusy Tiseo, G. Marchetti, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2024), pp. 1-8
Closed Access | Times Cited: 1
Risk assessment and clinical implications of COVID-19 in multiple myeloma patients: A systematic review and meta-analysis
Sultan Mahmud, Md Faruk Hossain, Abdul Muyeed, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0308463-e0308463
Open Access | Times Cited: 1
Impact of SARS-CoV-2 on Viral Respiratory Infections in Patients with Hematological Malignancies
Antonio Giordano, Martina Quattrone, Marcello Viscovo, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1520-1520
Open Access | Times Cited: 1
Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments
Nicola Sgherza, Anna Mestice, Angela Maria Vittoria Larocca, et al.
Mediterranean Journal of Hematology and Infectious Diseases (2024) Vol. 16, Iss. 1, pp. e2024022-e2024022
Open Access
When Chinese patients with plasma cell disorders encountered the nationwide Omicron outbreak (December 2022): a real-world multicenter and multiregional study
Xincheng Jiang, Xiaoyan Han, Fengyan Jin, et al.
Hematology (2024) Vol. 29, Iss. 1
Open Access
Impaired SARS-CoV-2-Specific CD8+ T Cells After Infection or Vaccination but Robust Hybrid T Cell Immunity in Patients with Multiple Myeloma
Khalid Shoumariyeh, Benedikt Csernalabics, Elahe Salimi Alizei, et al.
Vaccines (2024) Vol. 12, Iss. 11, pp. 1249-1249
Open Access
Respiratory Viruses in Patients With Hematological Malignancy in Boreal Autumn/Winter 2023–2024: EPICOVIDEHA‐EPIFLUEHA Report
Jon Salmanton‐García, Francesco Marchesi, Milan Navrátil, et al.
American Journal of Hematology (2024) Vol. 100, Iss. 3, pp. 358-374
Open Access
Page 1

Scroll to top